World Drug Safety Congress Europe 2024
October 9-10, 2024 | Amsterdam RAI
Your RWD Solution for Informed Drug Safety Decisions.
Book a Meeting
See us at Booth 18
Resources
Where Real-World Data Meets Pharmacovigilance Excellence
At TriNetX, we are revolutionizing drug safety through our commitment to providing unparalleled access to real-world data insights. Our cutting-edge platforms, extensive data analytics, and a team of seasoned experts empower drug safety professionals to unlock the transformative potential of real-world data and real-world evidence in pharmacovigilance.
What truly sets us apart is our fully integrated, comprehensive, global, real-world data (RWD) and evidence that empowers users to make data-driven decisions. EVIDEX® makes the most complex and demanding signal detection and management requirements easier by refining signals through analytics supported by the power of TriNetX global RWD.
Discover What’s Next in PV at Booth 18
WDSC EU 2024, TriNetX, Booth #18
Exhibit Hall Hours:
- Wednesday, October 9
- Thursday, October 10
Visit us at Booth 18 to discover how TriNetX empowers drug safety professionals with actionable evidence, enhancing decision-making, and improving patient outcomes. Our team will be on hand to demonstrate the capabilities of EVIDEX®, answer your questions, and explore how we can support your pharmacovigilance and drug safety initiatives. Don’t miss the chance to learn more about our solutions and how we’re driving safer healthcare.
Connect with TriNetX Drug Safety Experts
Join us at the World Drug Safety Congress in Europe to explore how TriNetX can become your premier partner in the next generation of pharmacovigilance. Browse speaking engagements from the curated conference agenda below.
Enabling Patient-Centric Pharmacovigilance through Global Real-World Data
Track: Patient Centricity
Date/Time: Day 1; October 9; 12:45 – 13:05
Location: Automation, G104
Speaker: Robert Kyle, Vice President, Product for Pharmacovigilance, TriNetX
Join us as we explore the pivotal role of real-world data (RWD) in enhancing patient-centricity within pharmacovigilance (PV). The presentation will highlight how leveraging RWD on a global scale can provide an accelerated understanding of potential risks of signals highlighted in post-market sources. We will delve into the necessity of analyzing deep clinical-level data from EHR sources to capture the full spectrum of potential causes for drug-event associated risks.
At WDSC EU, we’re proud to present how real-world data can provide rapid actionable insights, helping drug safety professionals evaluate safety signals with confidence and precision.
Signal Detection & Management Panel – Integration of real-world data into signal detection activities
Track: Signal Detection & Management
Date/Time: Day 2; October 10; 14:25 – 15:20
Location: Signal Detection & Management, Exhibition Hall
Moderator:
- Akhilesh Chamediya, Global Medical Director, Patient Safety Lead, Alexion & AstraZeneca
Panelists:
- Stéphanie Tcherny-Lessenot, Global Head, Benefit-Risk Evaluation, Sanofi
- Thomas Organ, Safety Science Director, Neuroscience, Global Patient Safety, Ipsen
- Maulik Mehta, President, Safety and Pharmacovigilance, TriNetX
In this insightful panel discussion, industry experts will explore how real-world data (RWD) is transforming signal detection activities within pharmacovigilance. The session will delve into the challenges and opportunities of incorporating RWD into safety monitoring, discussing how it can enhance early detection of potential safety signals and improve overall drug safety. Join this dynamic discussion to gain valuable insights into the practical applications, best practices, and future trends in integrating real-world data to support effective pharmacovigilance activities.
The World Drug Safety Congress EU is an invaluable opportunity to connect with industry leaders who share our commitment to advancing drug safety by empowering pharmacovigilance professionals with real-world evidence. This will enable them to make more informed decisions that enhance patient safety and drive better outcomes.
Pre-Book Meetings with TriNetX
Join us at WDSC EU 2024 to explore how TriNetX can enhance your pharmacovigilance capabilities. Meet our subject-matter experts to discuss how our real-world data solutions can support your specific drug safety needs and contribute to advancing safety in Europe and beyond.
Drug Safety Resources
Explore our curated collection of high-quality materials designed to support pharmacovigilance professionals, researchers, and industry stakeholders.
Webinar: Go Beyond the Limits of Legacy PV with RWD
The revolution in drug safety data is underway. The advent of RWD, together with technologies to aggregate, standardize, and analyze it, have turned Pharmacovigilance (PV) specialists into evidence generation leaders.
Download: GVP Module IX for Signal Management Guide
Good Pharmacovigilance Practices (GVP) are a set of measures put into practice in 2012 to facilitate the performance of pharmacovigilance in the European Union (EU). GVP is divided into several modules that govern different aspects of pharmacovigilance processes.
Product Preview: EVIDEX®
See how the EVIDEX® platform makes the most complex and demanding signal detection and management requirements easier by refining signals through analytics supported by the power of TriNetX global RWD.
Explore TriNetX PV Publications & Resources
TriNetX aims to advance pharmacovigilance by delivering cutting-edge research, in-depth publications, and essential resources. Discover valuable insights and tools to enhance your understanding and practice of drug safety and signal management.
Let’s Talk
Reserve your time with TriNetX experts live at WDSC EU 2024. Space is limited.
Our Mission
Our mission is to build a global data and analytics ecosystem that provides real-world insights to address the most pressing health challenges. This mission resonates beyond the walls of our organization, echoing in the corridors of our esteemed health care and industry partners. Every decision, innovation, and feature is fueled by our unwavering dedication to positively connect the world to improve human health.
Going Beyond What's Possible
As a global force, TriNetX continues to navigate uncharted territories with an unwavering commitment to revolutionizing the healthcare ecosystem.
Far beyond being a repository of information, TriNetX serves as a strategic partner in connecting health systems, providers, and researchers worldwide through our extensive real-world patient data that runs a mile wide and a mile deep.
From trial operations to evidence generation, we put you at the forefront of discovery.
Clinical Trial Design & Optimization
Data Sets & Analytics
Non-US Oncology
Real-World Evidence Generation
Pharmacovigilance & Drug Safety
Book a Meeting at WDSC EU
Please complete the below to request a meeting at the World Drug Safety Congress Europe 2024 in Amsterdam this October 9-10, 2024.